InvestorsHub Logo

sizzleweed

07/13/17 1:46 AM

#31071 RE: mrMando #31070

RGBP and leukemia specific treatments. maybe our patents get bought or developed. this may be good timing after efficacy evaluations are complete and show amazing promise, imo

sizzleweed

07/13/17 1:48 AM

#31072 RE: mrMando #31070

RGBP

If the F.D.A. accepts the recommendation, which is likely, the treatment will be the first gene therapy ever to reach the market. Others are expected: Researchers and drug companies have been engaged in intense competition for decades to reach this milestone. Novartis is now poised to be the first. Its treatment is for a type of leukemia, and it is working on similar types of treatments in hundreds of patients for another form of the disease, as well as multiple myeloma and an aggressive brain tumor.